MOTIVATION: The prioritization and identification of disease-causing mutations is one of the most significant challenges in medical genomics. Currently available methods address this problem for non-synonymous single nucleotide variants (SNVs) and variation in promoters/enhancers; however, recent research has implicated synonymous (silent) exonic mutations in a number of disorders. RESULTS: We have curated 33 such variants from literature and developed the Silent Variant Analyzer (SilVA), a machine-learning approach to separate these from among a large set of rare polymorphisms. We evaluate SilVA's performance on in silico 'infection' experiments, in which we implant known disease-causing mutations into a human genome, and show that for 15 of 33 disorders, we rank the implanted mutation among the top five most deleterious ones. Furthermore, we apply the SilVA method to two additional datasets: synonymous variants associated with Meckel syndrome, and a collection of silent variants clinically observed and stratified by a molecular diagnostics laboratory, and show that SilVA is able to accurately predict the harmfulness of silent variants in these datasets. AVAILABILITY: SilVA is open source and is freely available from the project website: http://compbio.cs.toronto.edu/silva CONTACT: silva-snv@cs.toronto.edu SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
MOTIVATION: The prioritization and identification of disease-causing mutations is one of the most significant challenges in medical genomics. Currently available methods address this problem for non-synonymous single nucleotide variants (SNVs) and variation in promoters/enhancers; however, recent research has implicated synonymous (silent) exonic mutations in a number of disorders. RESULTS: We have curated 33 such variants from literature and developed the Silent Variant Analyzer (SilVA), a machine-learning approach to separate these from among a large set of rare polymorphisms. We evaluate SilVA's performance on in silico 'infection' experiments, in which we implant known disease-causing mutations into a human genome, and show that for 15 of 33 disorders, we rank the implanted mutation among the top five most deleterious ones. Furthermore, we apply the SilVA method to two additional datasets: synonymous variants associated with Meckel syndrome, and a collection of silent variants clinically observed and stratified by a molecular diagnostics laboratory, and show that SilVA is able to accurately predict the harmfulness of silent variants in these datasets. AVAILABILITY: SilVA is open source and is freely available from the project website: http://compbio.cs.toronto.edu/silva CONTACT: silva-snv@cs.toronto.edu SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
Authors: Jeffrey B S Gaither; Grant E Lammi; James L Li; David M Gordon; Harkness C Kuck; Benjamin J Kelly; James R Fitch; Peter White Journal: Gigascience Date: 2021-04-05 Impact factor: 6.524
Authors: Stephen M Mount; Žiga Avsec; Liran Carmel; Rita Casadio; Muhammed Hasan Çelik; Ken Chen; Jun Cheng; Noa E Cohen; William G Fairbrother; Tzila Fenesh; Julien Gagneur; Valer Gotea; Tamar Holzer; Chiao-Feng Lin; Pier Luigi Martelli; Tatsuhiko Naito; Thi Yen Duong Nguyen; Castrense Savojardo; Ron Unger; Robert Wang; Yuedong Yang; Huiying Zhao Journal: Hum Mutat Date: 2019-08-19 Impact factor: 4.878
Authors: Settara C Chandrasekharappa; Steven B Chinn; Frank X Donovan; Naweed I Chowdhury; Aparna Kamat; Adebowale A Adeyemo; James W Thomas; Meghana Vemulapalli; Caroline S Hussey; Holly H Reid; James C Mullikin; Qingyi Wei; Erich M Sturgis Journal: Cancer Date: 2017-07-05 Impact factor: 6.860
Authors: Oscar A Moreno-Ramos; Ana María Olivares; Neena B Haider; Liga Colombiana de Autismo; María Claudia Lattig Journal: PLoS One Date: 2015-09-09 Impact factor: 3.240